How Merxin is revolutionizing the development & supply model of the $10 billion inhaler market controlled by pharmaceutical giants
With a solid $25 million investment, this Australia-based Institute is delving into RNA therapeutics
Leading dental services group partners with technology solutions platform to help SME clinics overcome barriers to growth
Jade Biomedical Completes Series B Financing to expand its biologics testing services (Bio-Pacific Laboratories, BPL) and operations
